Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/unpaywall/systemic-inflammation-blood-brain-barrier-vulnerability-and-cognitive-fmzMzki87X
References (130)
-
P. Aisen, K. Schafer, M. Grundman, E. Pfeiffer, M. Sano, K. Davis, M. Farlow, Shelia Jin, Ronald Thomas, L. Thal (2003)
Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial.JAMA, 289 21
-
Catherine Kinnecom, M. Lev, L. Wendell, E. Smith, J. Rosand, M. Frosch, S. Greenberg (2007)
Course of cerebral amyloid angiopathy–related inflammationNeurology, 68
-
(1909)
Vasc. Biol -
G. Lim, Fusheng Yang, T. Chu, Patrick Chen, W. Beech, B. Teter, Tracy Tran, O. Ubeda, K. Ashe, S. Frautschy, G. Cole (2000)
Ibuprofen Suppresses Plaque Pathology and Inflammation in a Mouse Model for Alzheimer's DiseaseThe Journal of Neuroscience, 20
-
N. Abbott, L. Rönnbäck, E. Hansson (2006)
Astrocyte–endothelial interactions at the blood–brain barrierNature Reviews Neuroscience, 7
-
Frontiers in Aging Neuroscience www.frontiersin -
S. Greenberg, M. Gurol, J. Rosand, Eric Smith (2004)
Amyloid Angiopathy–Related Vascular Cognitive ImpairmentStroke, 35
-
G. Tambussi, A. Gori, B. Capiluppi, C. Balotta, L. Papagno, B. Morandini, M. Pietro, D. Ciuffreda, A. Saracco, A. Lazzarin (2010)
Central Nervous -
I. Skoog, D. Gustafson (2003)
Hypertension, hypertension-clustering factors and Alzheimer's diseaseNeurological Research, 25
-
Simantini Ghosh, Michael Wu, S. Shaftel, S. Kyrkanides, F. LaFerla, J. Olschowka, M. O’Banion (2013)
Sustained Interleukin-1β Overexpression Exacerbates Tau Pathology Despite Reduced Amyloid Burden in an Alzheimer's Mouse ModelThe Journal of Neuroscience, 33
-
Zlokovic (2011)
Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disordersNat. Rev. Neurosci., 12
-
D. Muresanu, A. Popa-Wagner, A. Stan, A. Buga, B. Popescu (2014)
The vascular component of Alzheimer's disease.Current neurovascular research, 11 2
-
M. Pfeifer, S. Boncristiano, L. Bondolfi, A. Stalder, T. Deller, M. Staufenbiel, P. Mathews, M. Jucker (2002)
Cerebral hemorrhage after passive anti-Abeta immunotherapy.Science, 298 5597
-
S. Garbuzova-Davis, P. Sanberg (2014)
Blood-CNS Barrier Impairment in ALS patients versus an animal modelFrontiers in Cellular Neuroscience, 8
-
Q. Yan, Jianhua Zhang, Hantao Liu, S. Babu-Khan, R. Vassar, A. Biere, M. Citron, G. Landreth (2003)
Anti-Inflammatory Drug Therapy Alters β-Amyloid Processing and Deposition in an Animal Model of Alzheimer's DiseaseThe Journal of Neuroscience, 23
-
A. Ott, R.P. Stolk, F. Harskamp, H. Pols, A. Hofman, M. Breteler (1999)
Diabetes mellitus and the risk of dementiaNeurology, 53
-
S. Takeda, N. Sato, K. Uchio‐Yamada, Kyoko Sawada, Takanori Kunieda, Daisuke Takeuchi, H. Kurinami, M. Shinohara, H. Rakugi, R. Morishita (2010)
Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Aβ deposition in an Alzheimer mouse model with diabetesProceedings of the National Academy of Sciences, 107
-
S. Haga, K. Akai, T. Ishii (1989)
Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brainActa Neuropathologica, 77
-
H. Lassmann, J. Horssen, D. Mahad (2012)
Progressive multiple sclerosis: pathology and pathogenesisNature Reviews Neurology, 8
-
A. Koyama, J. O’Brien, J. Weuve, D. Blacker, Andrea Metti, K. Yaffe (2013)
The role of peripheral inflammatory markers in dementia and Alzheimer's disease: a meta-analysis.The journals of gerontology. Series A, Biological sciences and medical sciences, 68 4
-
Nicholas Dunn, M. Mullee, V. Perry, C. Holmes (2005)
Association between Dementia and Infectious Disease: Evidence from a Case-Control StudyAlzheimer Disease & Associated Disorders, 19
-
R. Shrestha, O. Millington, James Brewer, Trevor Bushell (2014)
Is central nervous system an immune-privileged site?Kathmandu University medical journal, 11 41
-
A. Griciuc, A. Serrano‐Pozo, A. Parrado, Andrea Lesinski, Caroline Asselin, K. Mullin, B. Hooli, Se Choi, B. Hyman, R. Tanzi (2013)
Alzheimer’s Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid BetaNeuron, 78
-
M. Hüll, M. Berger, M. Heneka (2012)
Disease-Modifying Therapies in Alzheimer’s DiseaseDrugs, 66
-
Sheng (1996)
In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesisNeurobiol. Aging, 17
-
N. Sato, S. Takeda, K. Uchio‐Yamada, H. Ueda, T. Fujisawa, H. Rakugi, R. Morishita (2011)
Role of insulin signaling in the interaction between Alzheimer disease and diabetes mellitus: a missing link to therapeutic potential.Current aging science, 4 2
-
C. Iadecola (2010)
The overlap between neurodegenerative and vascular factors in the pathogenesis of dementiaActa Neuropathologica, 120
-
M. Margallo-Lana, A. Swann, J. O'brien, A. Fairbairn, K. Reichelt, Dawn Potkins, P. Mynt, C. Ballard (2001)
Prevalence and pharmacological management of behavioural and psychological symptoms amongst dementia sufferers living in care environmentsInternational Journal of Geriatric Psychiatry, 16
-
(2014)
Systemic inflammation, bloodbrain barrier vulnerability and cognitive/non-cognitive symptoms in Alzheimer disease: relevance to pathogenesis and therapy -
W. Thies, Laura Bleiler (2013)
2013 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 9
-
J. Sundelöf, L. Kilander, J. Helmersson, A. Larsson, E. Rönnemaa, Malin Degerman-Gunnarsson, H. Basun, L. Lannfelt, S. Basu (2009)
Systemic inflammation and the risk of Alzheimer's disease and dementia: a prospective population-based study.Journal of Alzheimer's disease : JAD, 18 1
-
J. Wardlaw, P. Sandercock, M. Dennis, J. Starr (2003)
Is Breakdown of the Blood-Brain Barrier Responsible for Lacunar Stroke, Leukoaraiosis, and Dementia?Stroke: Journal of the American Heart Association, 34
-
Thies (2013)
2013 Alzheimer’s disease facts and figuresAlzheimers Dement., 9
-
J. Neuroinflammation -
Lauren Willard, B. Hauss-Wegrzyniak, Gary Wenk (1999)
Pathological and biochemical consequences of acute and chronic neuroinflammation within the basal forebrain cholinergic system of ratsNeuroscience, 88
-
Bin Ji, J. Maeda, M. Sawada, M. Ono, T. Okauchi, M. Inaji, Ming-Rong Zhang, Kazutoshi Suzuki, K. Ando, M. Staufenbiel, J. Trojanowski, V. Lee, M. Higuchi, T. Suhara (2008)
Imaging of Peripheral Benzodiazepine Receptor Expression as Biomarkers of Detrimental versus Beneficial Glial Responses in Mouse Models of Alzheimer's and Other CNS PathologiesThe Journal of Neuroscience, 28
-
Craft (2005)
Interleukin 1 receptor antagonist knockout mice show enhanced microglial activation and neuronal damage induced by intracerebroventricular infusion of human beta-amyloidJ. Neuroinflammation, 2
-
M. Kat, R. Vreeswijk, J. Jonghe, T. Ploeg, W. Gool, P. Eikelenboom, K. Kalisvaart (2008)
Long-Term Cognitive Outcome of Delirium in Elderly Hip Surgery PatientsDementia and Geriatric Cognitive Disorders, 26
-
M. Dehouck, S. Méresse, P. Delorme, J. Fruchart, R. Cecchelli (1990)
An Easier, Reproducible, and Mass‐Production Method to Study the Blood–Brain Barrier In VitroJournal of Neurochemistry, 54
-
S. Shaftel, S. Kyrkanides, J. Olschowka, Jen-nie Miller, Renee Johnson, M. O’Banion (2007)
Sustained hippocampal IL-1 beta overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology.The Journal of clinical investigation, 117 6
-
P. Mcgeer, M. Schulzer, E. Mcgeer (1996)
Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's diseaseNeurology, 47
-
C. Iadecola (2013)
The Pathobiology of Vascular DementiaNeuron, 80
-
D. Selkoe (2011)
Alzheimer's disease.Cold Spring Harbor perspectives in biology, 3 7
-
C. Lyketsos, Martin Steinberg, J. Breitner, J. Tschanz, Maria Norton, D. Steffens (2000)
Mental and behavioral disturbances in dementia: Findings from the cache county study on memory in agingNeurobiology of Aging, 21
-
J. Delrieu, P. Ousset, C. Caillaud, B. Vellas (2012)
‘Clinical trials in Alzheimer’s disease’: immunotherapy approachesJournal of Neurochemistry, 120
-
E. Winkler, Jesse Sengillo, A. Sagare, Zhen Zhao, Qingyi Ma, Edward Zuniga, Yaoming Wang, Zhihui Zhong, John Sullivan, J. Griffin, D. Cleveland, B. Zlokovic (2014)
Blood–spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model miceProceedings of the National Academy of Sciences, 111
-
E. Tarkowski, K. Blennow, A. Wallin, A. Tarkowski (1999)
Intracerebral Production of Tumor Necrosis Factor-α, a Local Neuroprotective Agent, in Alzheimer Disease and Vascular DementiaJournal of Clinical Immunology, 19
-
E. Vloeberghs, D. Dam, S. Engelborghs, G. Nagels, M. Staufenbiel, P. Deyn (2004)
Altered circadian locomotor activity in APP23 mice: a model for BPSD disturbancesEuropean Journal of Neuroscience, 20
-
J. Morris, C. Roe, C. Xiong, A. Fagan, A. Goate, D. Holtzman, M. Mintun (2010)
APOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal agingAnnals of Neurology, 67
-
J. Rogers, L. Kirby, S. Hempelman, D. Berry, P. Mcgeer, A. Kaszniak, J. Zalinski, M. Cofield, L. Mansukhani, P. Willson, F. Kogan (1993)
Clinical trial of indomethacin in Alzheimer's diseaseNeurology, 43
-
S. Frautschy, Fusheng Yang, Michael Irrizarry, B. Hyman, T. Saido, K. Hsiao, G. Cole (1998)
Microglial response to amyloid plaques in APPsw transgenic mice.The American journal of pathology, 152 1
-
T. Sacquegna, S. Guttmann, R. Agati, Roberto Gallassi, M. Leonardi (1990)
Leukoaraiosis and dementia.Stroke, 21 3
-
J. Prineas, J. Parratt (2012)
Oligodendrocytes and the early multiple sclerosis lesionAnnals of Neurology, 72
-
E. Wal, F. Gomez-Pinilla, C. Cotman (1993)
Transforming growth factor-beta 1 is in plaques in Alzheimer and Down pathologies.Neuroreport, 4 1
-
M. Ricci, P. Blasi, S. Giovagnoli, C. Róssi (2006)
Delivering drugs to the central nervous system: a medicinal chemistry or a pharmaceutical technology issue?Current medicinal chemistry, 13 15
-
McGeer (2000)
Cyclo-oxygenase-2 inhibitors: rationale and therapeutic potential for Alzheimer’s diseaseDrugs Aging, 17
-
M. McAllister, L. Križanac-Bengez, F. Macchia, R. Naftalin, K. Pedley, M. Mayberg, M. Marroni, S. Leaman, K. Stanness, D. Janigro (2001)
Mechanisms of glucose transport at the blood–brain barrier: an in vitro studyBrain Research, 904
-
Lyketsos (2000)
Mental and behavioral disturbances in dementia: findings from the cache county study on memory in agingAm. J. Psychiatry, 157
-
Priyanka Shahi, Serguei Loukianiouk, Andreas Bohne-Lang, M. Kenzelmann, Stefan Küffer, S. Maertens, Roland Eils, Hermann-Josef Gröne, Norbert Gretz, Benedikt Brors (2005)
Argonaute—a database for gene regulation by mammalian microRNAsNucleic Acids Research, 34
-
G. Burbach, A. Vlachos, E. Ghebremedhin, D. Turco, Janaky Coomaraswamy, M. Staufenbiel, M. Jucker, T. Deller (2007)
Vessel ultrastructure in APP23 transgenic mice after passive anti-Aβ immunotherapy and subsequent intracerebral hemorrhageNeurobiology of Aging, 28
-
Alain Simard, D. Soulet, G. Gowing, J. Julien, S. Rivest (2006)
Bone Marrow-Derived Microglia Play a Critical Role in Restricting Senile Plaque Formation in Alzheimer's DiseaseNeuron, 49
-
Mark Smith, S. Correia (2010)
Faculty Opinions recommendation of Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes. -
UC Irvine, PhD Rich, PhD Rasmusson, MD Folstein, K. Carson, MD Kawas, PhD Brandt, Dr. Stern (1995)
Nonsteroidal anti-inflammatory drugs in Alzheimer's diseaseNeurology, 45
-
W. Gool, D. Beek, P. Eikelenboom (2010)
Systemic infection and delirium: when cytokines and acetylcholine collideThe Lancet, 375
-
Catherine Trepanier, N. Milgram (2010)
Neuroinflammation in Alzheimer's disease: are NSAIDs and selective COX-2 inhibitors the next line of therapy?Journal of Alzheimer's disease : JAD, 21 4
-
J. Sheng, R. Mrak, K. Bales, B. Cordell, S. Paul, R. Jones, S. Woodward, X. Zhou, J. McGinness, W. Griffin (2000)
Overexpression of the neuritotrophic cytokine S100beta precedes the appearance of neuritic beta-amyloid plaques in APPV717F mice.Journal of neurochemistry, 74 1
-
Y. Chung, H. Ko, E. Bok, E. Park, S. Huh, J. Nam, B. Jin (2010)
The role of neuroinflammation on the pathogenesis of Parkinson's disease.BMB reports, 43 4
-
C. Ballard, A. Corbett (2013)
Agitation and aggression in people with Alzheimer's diseaseCurrent Opinion in Psychiatry, 26
-
Paramita Chakrabarty, Karen Jansen-West, A. Beccard, C. Ceballos‐Diaz, Yona Levites, Christophe Verbeeck, A. Zubair, D. Dickson, T. Golde, Pritam Das (2010)
Massive gliosis induced by interleukin‐6 suppresses Aβ deposition in vivo: evidence against inflammation as a driving force for amyloid depositionThe FASEB Journal, 24
-
M. Pfeifer, S. Boncristiano, L. Bondolfi, A. Stalder, T. Deller, M. Staufenbiel, P. Mathews, M. Jucker (2002)
Cerebral Hemorrhage After Passive Anti-Aβ ImmunotherapyScience, 298
-
J. Maeda, Bin Ji, T. Irie, T. Tomiyama, M. Maruyama, T. Okauchi, M. Staufenbiel, N. Iwata, M. Ono, T. Saido, Kazutoshi Suzuki, H. Mori, M. Higuchi, T. Suhara (2007)
Longitudinal, Quantitative Assessment of Amyloid, Neuroinflammation, and Anti-Amyloid Treatment in a Living Mouse Model of Alzheimer's Disease Enabled by Positron Emission TomographyThe Journal of Neuroscience, 27
-
D. Dickstein, Kaan Biron, Maki Ujiie, C. Pfeifer, A. Jeffries, W. Jefferies (2006)
Aβ peptide immunization restores blood‐brain barrier integrity in Alzheimer diseaseThe FASEB Journal, 20
-
H. Akiyama, S. Barger, S. Barnum, B. Bradt, J. Bauer, G. Cole, N. Cooper, P. Eikelenboom, M. Emmerling, B. Fiebich, C. Finch, S. Frautschy, W. Griffin, H. Hampel, M. Hull, G. Landreth, L. Lue, R. Mrak, I. Mackenzie, P. Mcgeer, M. O’Banion, J. Pachter, G. Pasinetti, C. Plata-salamán, J. Rogers, R. Rydel, Yong Shen, W. Streit, R. Strohmeyer, Ikuo Tooyoma, F. Muiswinkel, R. Veerhuis, D. Walker, S. Webster, Beatrice Wegrzyniak, G. Wenk, T. Wyss-Coray (2000)
Inflammation and Alzheimer’s diseaseNeurobiology of Aging, 21
-
J. Sheng, Kazuhiro Ito, R. Skinner, R. Mrak, C. Rovnaghi, L. Eldik, W. Griffin (1996)
In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesisNeurobiology of Aging, 17
-
T. Suhara, J. Magrané, K. Rosen, R. Christensen, Hyo‐Soo Kim, B. Zheng, D. McPhie, K. Walsh, H. Querfurth (2003)
Aβ42 generation is toxic to endothelial cells and inhibits eNOS function through an Akt/GSK-3β signaling-dependent mechanismNeurobiology of Aging, 24
-
Margallo-Lana (2001)
Prevalence and pharmacological management of behavioural and psychological symptoms amongst dementia sufferers living in care environmentsInt. J. Geriatr. Psychiatry, 16
-
Margaret Racke, Laura Boone, D. Hepburn, Maia Parsadainian, Matt Bryan, D. Ness, K. Piroozi, W. Jordan, Donna Brown, W. Hoffman, D. Holtzman, K. Bales, B. Gitter, P. May, S. Paul, R. DeMattos (2005)
Exacerbation of Cerebral Amyloid Angiopathy-Associated Microhemorrhage in Amyloid Precursor Protein Transgenic Mice by Immunotherapy Is Dependent on Antibody Recognition of Deposited Forms of Amyloid βThe Journal of Neuroscience, 25
-
B. Zlokovic (2011)
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disordersNature Reviews Neuroscience, 12
-
J. Godbout, Rodney Johnson (2006)
Age and neuroinflammation: a lifetime of psychoneuroimmune consequences.Neurologic clinics, 24 3
-
S. Takeda, N. Sato, K. Ikimura, H. Nishino, H. Rakugi, R. Morishita (2013)
Increased blood–brain barrier vulnerability to systemic inflammation in an Alzheimer disease mouse modelNeurobiology of Aging, 34
-
Marion Ebersoldt, T. Sharshar, D. Annane (2007)
Sepsis-associated deliriumIntensive Care Medicine, 33
-
M. Janelsins, M. Mastrangelo, S. Oddo, F. LaFerla, H. Federoff, W. Bowers (2005)
Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease miceJournal of Neuroinflammation, 2
-
K. Ikeda (1996)
[Apolipoprotein E and its receptors in Alzheimer's disease].Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme, 41 10
-
(2013)
Bleiler, L., and Alzheimer’s Association -
G. Bu (2009)
Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapyNature Reviews Neuroscience, 10
-
M. Gentile, R. Poulet, A. Pardo, G. Cifelli, A. Maffei, C. Vecchione, F. Passarelli, A. Landolfi, P. Carullo, G. Lembo (2009)
β-Amyloid deposition in brain is enhanced in mouse models of arterial hypertensionNeurobiology of Aging, 30
-
R. Bell, B. Zlokovic (2009)
Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s diseaseActa Neuropathologica, 118
-
Jonathan Godbout, Jing Chen, J. Abraham, A. Richwine, Brian Berg, Keith Kelley, Rodney Johnson (2005)
Exaggerated neuroinflammation and sickness behavior in aged mice after activation of the peripheral innate immune systemThe FASEB Journal, 19
-
A. Corbett, Jessica Smith, B. Creese, C. Ballard (2012)
Treatment of Behavioral and Psychological Symptoms of Alzheimer’s DiseaseCurrent Treatment Options in Neurology, 14
-
R. Bell, E. Winkler, I. Singh, A. Sagare, R. Deane, Zhenhua Wu, D. Holtzman, C. Betsholtz, A. Armulik, J. Sallstrom, B. Berk, B. Zlokovic (2012)
Apolipoprotein E controls cerebrovascular integrity via cyclophilin ANature, 485
-
A. Serrano‐Pozo, A. Muzikansky, T. Gómez-Isla, J. Growdon, R. Betensky, M. Frosch, B. Hyman (2013)
Differential relationships of reactive astrocytes and microglia to fibrillar amyloid deposits in Alzheimer disease.Journal of neuropathology and experimental neurology, 72 6
-
E. Bradshaw, L. Chibnik, B. Keenan, L. Ottoboni, T. Raj, A. Tang, Laura Rosenkrantz, S. Imboywa, Michelle Lee, Alina Korff, M. Morris, Denis Evans, Keith Johnson, R. Sperling, J. Schneider, D. Bennett, P. Jager (2013)
CD33 Alzheimer’s disease locus: Altered monocyte function and amyloid biologyNature neuroscience, 16
-
T. Tourdias, V. Dousset (2012)
Neuroinflammatory Imaging Biomarkers: Relevance to Multiple Sclerosis and its TherapyNeurotherapeutics, 10
-
D. Dickson, Sunhee Lee, L. Mattiace, S. Yen, C. Brosnan (1993)
Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's diseaseGlia, 7
-
Y. Matsuoka, M. Picciano, B. Malester, J. Lafrancois, C. Zehr, Joanna Daeschner, J. Olschowka, M. Fonseca, M. 'banion, A. Tenner, C. Lemere, K. Duff, Nathan Institute (2001)
Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease.The American journal of pathology, 158 4
-
F. Luo, N. Rustay, T. Seifert, Beate Roesner, V. Hradil, H. Hillen, U. Ebert, Jean Severin, B. Cox, D. Llano, M. Day, G. Fox (2010)
Magnetic Resonance Imaging Detection and Time Course of Cerebral Microhemorrhages during Passive Immunotherapy in Living Amyloid Precursor Protein Transgenic MiceJournal of Pharmacology and Experimental Therapeutics, 335
-
G. Lim, Fusheng Yang, T. Chu, E. Gahtan, O. Ubeda, W. Beech, J. Overmier, K. Hsiao-Ashec, S. Frautschy, G. Cole (2001)
Ibuprofen effects on Alzheimer pathology and open field activity in APPsw transgenic miceNeurobiology of Aging, 22
-
C. Holmes, J. Butchart (2011)
Systemic inflammation and Alzheimer's disease.Biochemical Society transactions, 39 4
-
Maki Ujiie, D. Dickstein, D. Carlow, W. Jefferies (2003)
Blood—Brain Barrier Permeability Precedes Senile Plaque Formation in an Alzheimer Disease ModelMicrocirculation, 10
-
Maryse Letièmbre, Yang Liu, S. Walter, W. Hao, T. Pfander, A. Wrede, W. Schulz-Schaeffer, K. Fassbender (2009)
Screening of innate immune receptors in neurodegenerative diseases: A similar patternNeurobiology of Aging, 30
-
J. Hardy, D. Selkoe (2009)
The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics -
W. Griffin, J. Sheng, G. Roberts, R. Mrak (1995)
Interleukin‐1 Expression in Different Plaque Types in Alzheimer's Disease: Significance in Plaque EvalutionJournal of Neuropathology and Experimental Neurology, 54
-
S. Takeda, N. Sato, Daisuke Takeuchi, H. Kurinami, M. Shinohara, K. Niisato, M. Kano, T. Ogihara, H. Rakugi, R. Morishita (2009)
Angiotensin Receptor Blocker Prevented &bgr;-Amyloid–Induced Cognitive Impairment Associated With Recovery of Neurovascular CouplingHypertension, 54
-
Šimon Scharf, Alastair Mander, A. Ugoni, F. Vajda, N. Christophidis (1999)
A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer’s diseaseNeurology, 53
-
Lee (2010)
Inflammation and Alzheimer’s diseaseArch. Pharm. Res., 33
-
S. Ryu, C. Katona, B. Rive, G. Livingston (2005)
Persistence of and changes in neuropsychiatric symptoms in Alzheimer disease over 6 months: the LASER-AD study.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 13 11
-
T. Suhara, J. Magrané, K. Rosen, R. Christensen, Hyo‐Soo Kim, B. Zheng, D. McPhie, K. Walsh, H. Querfurth (2003)
Abeta42 generation is toxic to endothelial cells and inhibits eNOS function through an Akt/GSK-3beta signaling-dependent mechanism.Neurobiology of aging, 24 3
-
J. Sheng, R. Mrak, K. Bales, B. Cordell, S. Paul, R. Jones, S. Woodward, X. Zhou, J. McGinness, W. Griffin (2000)
Overexpression of the Neuritotrophic Cytokine S100β Precedes the Appearance of Neuritic β‐Amyloid Plaques in APPV717F MiceJournal of Neurochemistry, 74
-
E. Reiman, Kewei Chen, Xiaofen Liu, D. Bandy, Meixiang Yu, Wendy Lee, Napatkamon Ayutyanont, J. Keppler, Stephanie Reeder, J. Langbaum, G. Alexander, W. Klunk, C. Mathis, J. Price, H. Aizenstein, S. DeKosky, R. Caselli (2009)
Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's diseaseProceedings of the National Academy of Sciences, 106
-
S. Reines, Gilbert Block, J. Morris, G. Liu, M. Nessly, Christopher Lines, B. Norman, C. Baranak (2004)
RofecoxibNeurology, 62
-
J. Breitner, B. Gau, K. Welsh, B. Plassman, W. McDonald, M. Helms, J. Anthony (1994)
Inverse association of anti‐inflammatory treatments and Alzheimer's diseaseNeurology, 44
-
N. Quan, W. Banks (2007)
Brain-immune communication pathwaysBrain, Behavior, and Immunity, 21
-
A. Bartels (2011)
Blood-brain barrier P-glycoprotein function in neurodegenerative disease.Current pharmaceutical design, 17 26
-
J. Pathol -
S. Salloway, J. Mintzer, M. Weiner, J. Cummings (2008)
Disease-modifying therapies in Alzheimer’s disease ⁎ ⁎ EDITOR’S NOTE: The Journal intended to include this article in the January 2008 supplement, “Leon Thal Symposium on Prevention of Dementia.”Alzheimer's & Dementia, 4
-
S. Takeda, N. Sato, T. Ogihara, R. Morishita (2008)
The renin-angiotensin system, hypertension and cognitive dysfunction in Alzheimer's disease: new therapeutic potential.Frontiers in bioscience : a journal and virtual library, 13
-
C. Hall, C. Reynell, Bodil Gesslein, N. Hamilton, Anusha Mishra, B. Sutherland, F. O'Farrell, A. Buchan, M. Lauritzen, D. Attwell (2014)
Capillary pericytes regulate cerebral blood flow in health and diseaseNature, 508
-
E. Wal, F. Gomez-Pinilla, C. Cotman (1993)
Transforming growth factor-β1 is in plaques in Alzheimer and Down pathologiesNeuroreport, 4
-
E. Vloeberghs, D. Dam, F. Franck, M. Staufenbiel, P. Deyn (2007)
Mood and male sexual behaviour in the APP23 model of Alzheimer's diseaseBehavioural Brain Research, 180
-
T. Strandberg (2003)
Alzheimer's disease and angiogenesisThe Lancet, 361
-
Journal of Neuroinflammation Microglial Inflammation in the Parkinsonian Substantia Nigra: Relationship to Alpha-synuclein Deposition -
A. Ott (1997)
Risk of dementia: The Rotterdam Study -
S. Hayashi, N. Sato, A. Yamamoto, Y. Ikegame, S. Nakashima, T. Ogihara, R. Morishita (2009)
Alzheimer Disease–Associated Peptide, Amyloid &bgr;40, Inhibits Vascular Regeneration With Induction of Endothelial AutophagyArteriosclerosis, Thrombosis, and Vascular Biology, 29
-
E. Neuwelt, B. Bauer, C. Fahlke, G. Fricker, C. Iadecola, D. Janigro, L. Leybaert, Z. Molnár, M. O’Donnell, J. Povlishock, N. Saunders, F. Sharp, D. Stanimirovic, R. Watts, L. Drewes (2011)
Engaging neuroscience to advance translational research in brain barrier biologyNature Reviews Neuroscience, 12
-
R. Mrak, J. Sheng, W. Griffin (1996)
Correlation of Astrocytic S100β Expression with Dystrophic Neurites in Amyloid Plaques of Alzheimer's DiseaseJournal of Neuropathology and Experimental Neurology, 55
-
N. Sato, R. Morishita (2013)
Roles of vascular and metabolic components in cognitive dysfunction of Alzheimer disease: short- and long-term modification by non-genetic risk factorsFrontiers in Aging Neuroscience, 5
-
K. Iqbal, I. Grundke‐Iqbal (2006)
Discoveries of tau, abnormally hyperphosphorylated tau and others of neurofibrillary degeneration: a personal historical perspective.Journal of Alzheimer's disease : JAD, 9 3 Suppl
-
M. Rodrigues, D. Hernandez-Ontiveros, Michael Louis, A. Willing, C. Borlongan, P. Sanberg, J. Voltarelli, S. Garbuzova-Davis (2012)
Neurovascular aspects of amyotrophic lateral sclerosis.International review of neurobiology, 102
-
Godbout (2009)
Age and neuroinflammation: a lifetime of psychoneuroimmune consequencesImmunol. Allergy Clin. North Am., 29
-
J. Bauer, S. Strauss, U. Schreiter-Gasser, U. Ganter, P. Schlegel, I. Witt, Benedikt Yolk, M. Berger (1991)
Interleukin‐6 and α‐2‐macroglobulin indicate an acute‐phase state in Alzheimer's disease corticesFEBS Letters, 285
- Publisher
- Unpaywall
- ISSN
- 1663-4365
- DOI
- 10.3389/fnagi.2014.00171
- Publisher site
- See Article on Publisher Site
Abstract
Journal
Frontiers in Aging Neuroscience – Unpaywall
Published: Jul 29, 2014